Want to track HAE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Haemonetics Corporation (HAE) Statistics
Valuation metrics
Market Cap 3.54B
Enterprise value 4.52B
Trailing P/E (ttm) 38.17
Forward P/E -
PEG ratio -0.99
Price/Sales (ttm) 2.65
Price/Book (mrq) 4.52
Enterprise Value/Revenue 3.39
Enterprise Value/EBITDA 16.12
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 618.32K
Average volume (90 days) 880.77K
Price summary
52-Week low 47.32
52-Week high 87.32
Beta -
50-Day moving average 75.96
200-Day moving average 64.67
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 3 Dec 2012
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.07%
Operating margin 0.18%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 28.86
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.31
Total debt (mrq) -
Total Debt/Equity (mrq) 1.54
Current ratio (mrq) 2.95%
Book value per share (mrq) 17.23
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
